Jeffrey W. Sherman, EVP and Chief Medical Officer at Horizon Pharma plc (HZNP), sold 7,750 shares at $31.78 ($246K) on 2015-09-21, disclosed to the SEC on 2015-09-21.
Scheduled sale ($246k) by EVP and Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XERS | BUY | 2023-11-29 | $10K | — | Filing → |
| HZNP | SELL | 2023-01-12 | $1.5M | — | Filing → |
| HZNP | SELL | 2023-01-06 | $1.2M | — | Filing → |